WHO Restricts Ervebo Use in Bundibugyo Outbreak
4 Articles
4 Articles
WHO restricts Ervebo use in Bundibugyo outbreak
WHO said Ervebo should currently be used against Bundibugyo virus only within a research protocol to generate evidence on its effectiveness, rather than through broader routine outbreak vaccination. The post WHO restricts Ervebo use in Bundibugyo outbreak appeared first on Premium Times Nigeria.
The World Health Organization (WHO) has issued new updated emergency use guidelines regarding the potential use of Ervebo®, the only licensed vaccine against Ebola disease.
WHO rejects wide rollout of Ervebo Vaccine in deadly DR Congo Ebola outbreak
The World Health Organization (WHO) has rejected the programmatic rollout of the Ervebo Ebola vaccine against the Bundibugyo strain currently driving the Democratic Republic of Congo’s deadliest Ebola outbreak, saying available evidence remains insufficient to establish whether the vaccine provides meaningful protection against the virus. The post WHO rejects wide rollout of Ervebo Vaccine in deadly DR Congo Ebola outbreak appeared first on Nair…
After the extraordinary meeting of the Sage, the Oms updates the recommendations: against the virus Bundibugyo Ervebo should be used in the framework of research protocols, prioritising randomized studies with ring vaccination. Among the priorities also accelerate the development of specific vaccines for BDBV. The post Virus ebola Bundibugyo. Oms publishes new guidelines for the emerging use of the vaccine Ervebo appeared first on Quotidiano San…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
